Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Merger | Merged

About Pear Tree Pharmaceuticals

Pear Tree Pharmaceuticals operates as a development stage pharmaceutical company which engages in the development and commercialization of pharmaceuticals for aging women. It offers products that treat and prevent diseases, symptoms, and conditions associated with menopause and cancer chemotherapy.

Pear Tree Pharmaceuticals Headquarters Location

125 Cambridge Park Drive

Cambridge, Massachusetts, 02140,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Pear Tree Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Pear Tree Pharmaceuticals is included in 1 Expert Collection, including Women's Health & Wellness.


Women's Health & Wellness

1,478 items

Startups focused on providing products and services catering to women's health and wellbeing.

Latest Pear Tree Pharmaceuticals News

Dare acquiring Pear Tree

May 21, 2018

Dare acquiring Pear Tree PDF Daré BioScience Inc. (NASDAQ:DARE) will acquire Pear Tree Pharmaceuticals Inc. (Cambridge, Mass. ), gaining its PT-101. The vaginal formulation of tamoxifen... Read the full 78 word article User Sign in Individual Use $30.00 USD What is BioCentury? BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

  • Where is Pear Tree Pharmaceuticals's headquarters?

    Pear Tree Pharmaceuticals's headquarters is located at 125 Cambridge Park Drive, Cambridge.

  • What is Pear Tree Pharmaceuticals's latest funding round?

    Pear Tree Pharmaceuticals's latest funding round is Merger.

  • Who are the investors of Pear Tree Pharmaceuticals?

    Investors of Pear Tree Pharmaceuticals include Dare Bioscience.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.